US 7166704
Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer
granted A61KA61K38/00
Quick answer
US patent 7166704 (Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
- Grant date
- Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00